Colorectal carcinomas with BRAF mutations show higher expression of PD-L1 (Srivastava et al., 2021), which can contribute to immune evasion of cancer cells and in turn nuclear PD-L1 promotes cell cycle progression of BRAF mutant cells (Ma et al., 2022). This evidence concerns the gene CD274 and colorectal carcinoma.